Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland
Recruiting · NCT05819463 · Observational (researchers observe without assigning treatment) · Lead sponsor: Swiss Society of Dermatology and Venereology
View the official record on ClinicalTrials.gov →What this trial is about
As structured and detailed data on the management of AD, a common chronic inflammatory skin disease which has a high impact on patients' quality of life and socioeconomic burden, are not available in Switzerland, the planned registry will overcome this gap. It will provide data on the medical care of patients with AD for health care research and allow to study the efficacy and safety of approved and available therapies for AD in daily life.
Who can take part
Age range
12 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age ≥ 12 years
- AD according to the UK Working Party's Diagnostic Criteria (28)
- Moderate to severe AD as defined by
- objective SCORAD \> 20 or IGA ≥ 3 (moderate) or
- currently on systemic antiinflammatory therapy for AD or
- previous systemic antiinflammatory therapy for AD within past 24 months
Exclusion criteria
- refusal to sign the informed consent form
Where it is running
9 locations listed.
- Universitätsspital Basel, Allergologie - Basel, Switzerland
- Inselspital, Department of Dermatology - Bern, Switzerland
- Dermatology & Skin Care Clinic - Buochs, Switzerland
- HFR Hôpital Cantonal de Fribourg - Fribourg, Switzerland
- Dermatologie CHUV - Lausanne, Switzerland
- Luzerner Kantonsspital, Zentrum für Dermatologie und Allergologie - Lucerne, Switzerland
- Kantonsspital St. Gallen - Klinik für Dermatologie, Venerologie und Allergologie - Sankt Gallen, Switzerland
- PLAZA Kliniken - Uster, Switzerland
- Institut für Dermatologie und Venerologie Stadtspital Zürich Europaallee - Zurich, Switzerland